Approval · Notice of Compliance 38421 · 2026
CAPRELSA: Notice of Compliance 38421
Issued October 7, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38421
- Date
- October 7, 2026
- Company
- Esteve Pharmaceuticals S.A.Barcelona, Barcelona, Spain
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
Medicinal ingredients
- VANDETANIB 100 MG per TAB
- VANDETANIB 300 MG per TAB